Hologic (HOLX) Posts Q3 adj.-EPS of $0.28, Tops by 1c; Guides Q110 EPS
More News related to HOLX
- New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity
- Notable Analyst Ratings Changes 11/25: EXXI, IWA, VPRT Upgraded; BNHN, NRG, GTE Downgraded
- Wells Fargo Initiates Coverage on Hologic (HOLX) with an Outperform
- Hologic (HOLX) Could See Pressure As Group Urges Mammograms at 50, Not 40
- Hologic to Feature Adiana(R) Permanent Contraception System at AAGL 2009
More News related to Earnings
- Unusual 11 Mid-Day Movers 11/30: SOMX, CLWT, KBX, CSGS Higher; AIG, BGP, BONT, HEB Lower
- Notable ETF Movers: SLX, EWJ, USO Higher; UNG, XRT Lower
- Best of the Web 11/30: Some Banks So Bad Buyers Won't Touch 'Em, Risky Bets Hurt Harvard, Eurozone Inflation Turns Positive
- Notable Analyst Rating Changes for 11/30: X, DE, AFL, AEO Upgraded; BIDU, SWY, BKC, SVU Downgraded
- Morning Movers 11/30: PEIX, CLRT, PROV, SOMX, OTIV Higher; HPOL, MELA Lower
Hologic (NASDAQ: HOLX) reports Q4 adjusted EPS of $0.28, 1 cent better than the analyst estimate of $0.27. Revenue for the quarter was $402.8 million, which compares to the estimate of $398.27 million.
Sees Q110 EPS $0.24 - $0.26, versus $0.30 consensus.
Related Categories
EarningsGuidance
Stocks Mentioned
-0.09Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
